Published in Stroke on April 30, 2009
Evaluating strategies for the treatment of cerebral cavernous malformations. Stroke (2010) 1.77
Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol (2011) 1.59
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology (2011) 1.50
Continued statin therapy could improve the outcome after spontaneous intracerebral hemorrhage. Neurosurg Rev (2012) 1.46
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89
Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol (2011) 0.89
Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care (2011) 0.85
The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage. Crit Care (2011) 0.83
Prior use of 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibitor, simvastatin fails to improve outcome after experimental intracerebral hemorrhage. J Korean Neurosurg Soc (2011) 0.78
The role of statins in neurosurgery. Neurosurg Rev (2010) 0.78
Statin use after intracerebral hemorrhage: a 10-year nationwide cohort study. Brain Behav (2016) 0.75
Atorvastatin in stroke: a review of SPARCL and subgroup analysis. Vasc Health Risk Manag (2010) 0.75
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med (2005) 2.22
Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease. Isr Med Assoc J (2004) 2.02
Long-term changes in serum cholesterol level does not influence the progression of coronary calcification. Int J Cardiol (2010) 1.99
Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology (2006) 1.65
Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology (2009) 1.64
Perceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute stroke. Stroke (2006) 1.63
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood (2008) 1.57
Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy. Neuroepidemiology (2012) 1.55
Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol (2007) 1.50
Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med (2006) 1.46
Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation (2008) 1.45
Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel. Isr Med Assoc J (2005) 1.41
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Isr Med Assoc J (2004) 1.39
Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke (2009) 1.25
Derivation and validation of the prolonged length of stay score in acute stroke patients. Neurology (2010) 1.23
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol (2006) 1.17
Two-dimensional intraventricular flow mapping by digital processing conventional color-Doppler echocardiography images. IEEE Trans Med Imaging (2010) 1.17
Spiral computed tomography evidence of close correlation between coronary and thoracic aorta calcifications. Atherosclerosis (2004) 1.11
A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis (2008) 1.11
Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients. Eur Heart J (2005) 1.09
Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol (2006) 1.09
Salvaging brain: new concepts in the management of acute stroke. Isr Med Assoc J (2004) 1.08
Chronic kidney disease in patients with acute intracerebral hemorrhage: association with large hematoma volume and poor outcome. Cerebrovasc Dis (2010) 1.04
Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J (2007) 0.99
Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol (2002) 0.99
Hospital disposition after stroke in a national survey of acute cerebrovascular diseases in Israel. Arch Phys Med Rehabil (2008) 0.98
Educational level as a modulator of cognitive performance and neuropsychyatric features in Parkinson disease. Cogn Behav Neurol (2007) 0.94
Cardiovascular events in patients received combined fibrate/statin treatment versus statin monotherapy: Acute Coronary Syndrome Israeli Surveys data. PLoS One (2012) 0.93
Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol (2004) 0.93
Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Am J Cardiol (2009) 0.92
Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke (2002) 0.92
Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil (2006) 0.92
Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes. Atherosclerosis (2006) 0.92
Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol (2004) 0.90
Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging. J Am Coll Cardiol (2002) 0.89
Diabetes, hyperglycemia and the management of cerebrovascular disease. Curr Opin Neurol (2011) 0.89
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med (2002) 0.88
Centenarian stroke treated with tissue-type plasminogen activator. Cerebrovasc Dis (2002) 0.88
Similarity of the swine vasculature to the human carotid bifurcation: analysis of arterial diameters. J Vasc Interv Radiol (2008) 0.87
Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke. Cerebrovasc Dis (2012) 0.87
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol (2008) 0.87
Should DWI MRI be the primary screening test for stroke? Int J Stroke (2014) 0.87
Quantitative detection of thrombin activity in an ischemic stroke model. J Mol Neurosci (2013) 0.86
The application of MRI for depiction of subtle blood brain barrier disruption in stroke. Int J Biol Sci (2010) 0.86
Thrombin regulation of synaptic plasticity: implications for physiology and pathology. Exp Neurol (2013) 0.86
Poor neighborhood socioeconomic status and risk of ischemic stroke after myocardial infarction. Epidemiology (2011) 0.86
Ischemic stroke due to acute basilar artery occlusion: proportion and outcomes. Isr Med Assoc J (2010) 0.85
Excellent rates of recanalization and good functional outcome after stent-based thrombectomy for acute middle cerebral artery occlusion. Is it time for a paradigm shift? J Clin Neurosci (2013) 0.85
Left ventricular diastolic function in trained male weight lifters at rest and during isometric exercise. Am J Cardiol (2008) 0.85
State-of-the-art reperfusion strategies for acute ischemic stroke. J Clin Neurosci (2011) 0.85
Preliminary experience with the use of self-expanding stent as a thrombectomy device in ischemic stroke. Neurol Res (2011) 0.85
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? J Neural Transm (Vienna) (2010) 0.84
Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Clin Neuropharmacol (2006) 0.84
Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage. Int J Stroke (2010) 0.84
Hemodynamic evaluation of embolic trajectory in an arterial bifurcation: an in-vitro experimental model. Stroke (2005) 0.84
Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology (2006) 0.83
Long-term benefit of high-density lipoprotein cholesterol-raising therapy with bezafibrate: 16-year mortality follow-up of the bezafibrate infarction prevention trial. Arch Intern Med (2009) 0.83
The anticoagulant activated protein C (aPC) promotes metaplasticity in the hippocampus through an EPCR-PAR1-S1P1 receptors dependent mechanism. Hippocampus (2014) 0.82
Apolipoproteins B and AI and the risk of ischemic cerebrovascular events in patients with pre-existing atherothrombotic disease. J Neurol Sci (2008) 0.82
Capturing the scope of stroke: silent, whispering, and overt. Arch Neurol (2009) 0.82
Gender differences in characteristics, management and outcome at discharge and three months after stroke in a national acute stroke registry. Int J Cardiol (2013) 0.81
Stroke in the very elderly: characteristics and outcome in patients aged ≥85 years with a first-ever ischemic stroke. Neuroepidemiology (2012) 0.81
Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Cardiovasc Diabetol (2008) 0.81
The frontal assessment battery as a tool for evaluation of frontal lobe dysfunction in patients with Parkinson disease. J Geriatr Psychiatry Neurol (2012) 0.81
Treating seizures and epilepsy with anticoagulants? Front Cell Neurosci (2013) 0.81
Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke. Am Heart J (2008) 0.81
Serum calcium levels and long-term mortality in patients with acute stroke. Cerebrovasc Dis (2010) 0.81
Extent of hypoattenuation on CT angiography source images in basilar artery occlusion: prognostic value in the Basilar Artery International Cooperation Study. Stroke (2011) 0.81
Usefulness of helical computed tomography in detection of mitral annular calcification as a marker of coronary artery disease. Int J Cardiol (2005) 0.80
Feasibility, safety and efficacy of an early aerobic rehabilitation program for patients after minor ischemic stroke: A pilot randomized controlled trial. NeuroRehabilitation (2011) 0.80
Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry. Blood Press (2014) 0.80
Trends in admission blood pressure and stroke outcome in patients with acute stroke and transient ischemic attack in a National Acute Stroke registry. J Hypertens (2016) 0.79
Stent-based thrombectomy versus intravenous tissue plasminogen activator in patients with acute middle cerebral artery occlusion. Stroke (2012) 0.79
Decompressive hemicraniectomy improves outcome in patients with failed arterial recanalization after acute carotid artery occlusion. Neurol Res (2010) 0.79
Burden and outcome of prevalent ischemic brain disease in a national acute stroke registry. Stroke (2013) 0.79
Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. J Stroke Cerebrovasc Dis (2010) 0.79
Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator. PM R (2010) 0.78
C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease. Am Heart J (2007) 0.78
Chlamydia pneumoniae and future risk in patients with coronary heart disease. Int J Cardiol (2004) 0.78
Novel therapies for acute ischemic stroke. Isr Med Assoc J (2006) 0.78
Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease. Clin Cardiol (2005) 0.78
Correlates of well-being among caregivers of long-term community-dwelling stroke survivors. Int J Rehabil Res (2016) 0.77
White blood cell count and the incidence of ischemic stroke in coronary heart disease patients. Am J Med (2005) 0.77
Anticoagulation remains underused in prevention of stroke associated with atrial fibrillation: insights from two consecutive national surveys. Int J Cardiol (2010) 0.77
Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in Israel. Stroke (2009) 0.77
[Guidelines for the management of stroke--2007 prevention of ischemic stroke--general approach and medical treatment]. Harefuah (2007) 0.77
Acute basilar artery occlusion in the Basilar Artery International Cooperation Study: does gender matter? Stroke (2010) 0.77
Body height and late-life cognition among patients with atherothrombotic disease. Alzheimer Dis Assoc Disord (2013) 0.77
Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy. Isr Med Assoc J (2007) 0.77
Intraarterial multi-modal reperfusion therapy for acute ischemic stroke: a10 year single-center experience. Isr Med Assoc J (2012) 0.77
Perceived hardships at midlife: prediction of long-term stroke mortality. Int J Cardiol (2013) 0.76